Ritholtz Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$410K Sell
1,464
-128
-8% -$33.6K 0.01% 928
2026
Q1
$425K Buy
1,592
+51
+3% +$13.8K 0.01% 843
2025
Q4
$387K Sell
1,541
-661
-30% -$176K 0.01% 807
2025
Q3
$632K Sell
2,202
-136
-6% -$36.4K 0.01% 615
2025
Q2
$614K Buy
2,338
+620
+36% +$151K 0.01% 585
2025
Q1
$400K Buy
1,718
+493
+40% +$120K 0.01% 651
2024
Q4
$281K Buy
+1,225
New +$281K 0.01% 728
2022
Q4
– Sell
-2,401
Closed -$423K – 668
2022
Q3
$423K Sell
2,401
-208
-8% -$42.6K 0.02% 446
2022
Q2
$525K Buy
2,609
+154
+6% +$32.8K 0.03% 308
2022
Q1
$556K Buy
2,455
+410
+20% +$96.4K 0.04% 285
2021
Q4
$552K Buy
2,045
+738
+56% +$183K 0.03% 281
2021
Q3
$316K Buy
+1,307
New +$329K 0.02% 361

Other funds holding LH

Ritholtz Wealth Management's LH Position: Q2 2026 in Review

Ritholtz Wealth Management reduced its Labcorp (LH) stake by 8% in Q2 2026, selling an estimated $33.6K and leaving 1,464 shares worth $410K. The position accounts for 0.01% of the portfolio, ranked #928.

Ritholtz Wealth Management first reported a position in LH in Q3 2021 and has held it in 12 quarters since. The position peaked at $632K in Q3 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Ritholtz Wealth Management held 1,464 shares of Labcorp worth $410K as of Q2 2026.
  • Ritholtz Wealth Management sold 128 Labcorp shares in Q2 2026, an estimated $33.6K.
  • Labcorp made up 0.01% of Ritholtz Wealth Management's portfolio in Q2 2026, its #928 holding.
  • Ritholtz Wealth Management first reported a position in Labcorp in Q3 2021 and has held it in 12 quarters since.
  • Ritholtz Wealth Management's Labcorp position peaked at $632K in Q3 2025.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.